Paper40990276
Cardiopulmonary Remodeling In Nondiabetic Patients with Systolic Heart Failure Using Sodium-Glucose Cotransporter 2 Inhibitors: An Updated Systematic Review and Meta-Analysis of Randomized Clinical Trials.
Chichagi F and 6 others. Curr Cardiol Rev, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Cardiopulmonary Remodeling In Nondiabetic Patients with Systolic Heart Failure Using Sodium-Glucose Cotransporter 2 Inhibitors: An Updated Systematic Review and Meta-Analysis of Randomized Clinical Trials. Papers, record 40990276. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40990276
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Cardiopulmonary Remodeling In Nondiabetic Patients with Systolic Heart Failure Using Sodium-Glucose Cotransporter 2 Inhibitors: An Updated Systematic Review and Meta-Analysis of Randomized Clinical Trials.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Sodium-Glucose Transporter 2 Inhibitors | Major topic |
| Heart Failure, Systolic | Major topic |
| Ventricular Remodeling | Major topic |
| Humans | |
| Randomized Controlled Trials as Topic | |
| Stroke Volume | |
| Ventricular Function, Left |
Source PubMed
References100
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24743145 | Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. | J Clin Invest | 2014 | https://conductscience.org/library/papers/24743145 | PubMed |
| 2 | 24398230 | The annual global economic burden of heart failure. | Int J Cardiol | 2014 | https://conductscience.org/library/papers/24398230 | PubMed |
| 3 | 33129742 | Empagliflozin Ameliorates Diastolic Dysfunction and Left Ventricular Fibrosis/Stiffness in Nondiabetic Heart Failure: A Multimodality Study. | JACC Cardiovasc Imaging | 2021 | https://conductscience.org/library/papers/33129742 | PubMed |
| 4 | 39544327 | Comprehensive Benefits of Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure With Reduced Ejection Fraction: A Literature Review. | J Clin Med Res | 2024 | https://conductscience.org/library/papers/39544327 | PubMed |
| 5 | 29203583 | How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial. | Diabetes Care | 2018 | https://conductscience.org/library/papers/29203583 | PubMed |
| 6 | 38771472 | The Efficacy and Safety of Sodium-Glucose Co-transporter 2 (SGLT2) Inhibitors in Real-World Clinical Practice: Potential Cautionary Use in Elderly Patients with Type 2 Diabetes (T2D). | Diabetes Ther | 2024 | https://conductscience.org/library/papers/38771472 | PubMed |
| 7 | 29603546 | Effects of empagliflozin on cardiorespiratory fitness and significant interaction of loop diuretics. | Diabetes Obes Metab | 2018 | https://conductscience.org/library/papers/29603546 | PubMed |
| 8 | 33496189 | Trajectories of Left Ventricular Ejection Fraction After Acute Decompensation for Systolic Heart Failure: Concomitant Echocardiographic and Systemic Changes, Predictors, and Impact on Clinical Outcomes. | J Am Heart Assoc | 2021 | https://conductscience.org/library/papers/33496189 | PubMed |
| 9 | 21146651 | Prediction of severe cardiovascular events by VE/VCO2 slope versus peak VO2 in systolic heart failure: a meta-analysis of the published literature. | Am Heart J | 2010 | https://conductscience.org/library/papers/21146651 | PubMed |
| 10 | 35902161 | Expenditure on Heart Failure in the United States: The Medical Expenditure Panel Survey 2009-2018. | JACC Heart Fail | 2022 | https://conductscience.org/library/papers/35902161 | PubMed |
| 11 | 33506641 | Crosstalk between exosomes and autophagy: A review of molecular mechanisms and therapies. | J Cell Mol Med | 2021 | https://conductscience.org/library/papers/33506641 | PubMed |
| 12 | 32415802 | The effects of canagliflozin compared to sitagliptin on cardiorespiratory fitness in type 2 diabetes mellitus and heart failure with reduced ejection fraction: The CANA-HF study. | Diabetes Metab Res Rev | 2020 | https://conductscience.org/library/papers/32415802 | PubMed |
| 13 | 27418546 | Impact of chronic systolic heart failure on lung structure-function relationships in large airways. | Physiol Rep | 2016 | https://conductscience.org/library/papers/27418546 | PubMed |
| 14 | 36308299 | Effect of ipragliflozin on carotid intima-media thickness in patients with type 2 diabetes: a multicenter, randomized, controlled trial. | Eur Heart J Cardiovasc Pharmacother | 2023 | https://conductscience.org/library/papers/36308299 | PubMed |
| 15 | 38803667 | SGLT2 inhibition, venous thrombolism, and death due to cardiac causes: a mediation Mendelian randomization study. | Front Cardiovasc Med | 2024 | https://conductscience.org/library/papers/38803667 | PubMed |
| 16 | 35363499 | 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. | Circulation | 2022 | https://conductscience.org/library/papers/35363499 | PubMed |
| 17 | 3594774 | Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. | Circulation | 1987 | https://conductscience.org/library/papers/3594774 | PubMed |
| 18 | 39866213 | Impact of sodium-glucose cotransporter-2 inhibitors on pulmonary vascular cell function and arterial remodeling. | World J Cardiol | 2025 | https://conductscience.org/library/papers/39866213 | PubMed |
| 19 | 36615133 | Left Ventricular Adverse Remodeling in Ischemic Heart Disease: Emerging Cardiac Magnetic Resonance Imaging Biomarkers. | J Clin Med | 2023 | https://conductscience.org/library/papers/36615133 | PubMed |
| 20 | 38644817 | SGLT-2 inhibitors as novel treatments of multiple organ fibrosis. | Heliyon | 2024 | https://conductscience.org/library/papers/38644817 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SLC5A2 | 6524 | PubTator's text mining | https://conductscience.org/library/genes/6524 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40990276
GET https://conductscience.org/api/papers/v1/40990276/references?page=2